SiteLabs provides technology that turns independent pharmacies into local hubs for preventive care and clinical research. Its platform enables in-pharmacy screenings for diabetes, heart disease, hypertension, cancer and other conditions, while also linking eligible patients to relevant clinical trials. By generating new revenue streams for pharmacies and expanding access to diagnostics, the company aims to lower costs and improve patient outcomes in underserved communities. The team blends expertise across pharmacy, healthcare, marketing and technology and is led by CEO Darren Schaupp. With its recent seed capital, SiteLabs plans to expand operations and accelerate product development. The company positions itself as a partner to independent pharmacies, addressing critical gaps in care and advancing population health.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2025